Delivery Order SPE2DB20D7066-SPE2DB25FC4NX
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s, with a ceiling value of $1,181.76. The award was made on July 21, 2025, as a firm fixed price delivery order with an ultimate completion date of July 22, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs, with performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $7,723.82. This firm fixed-price, non-set-aside contract is part of the company's broader relationship with the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceuticals and medical supplies to support military and federal healthcare systems. The order is scheduled for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 29, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $3,081.89 and a firm fixed-price structure. This competitively awarded delivery order, which carries no set-aside designation, is expected to reach ultimate completion on September 2, 2025, with performance taking place at the contractor's corporate office location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Lidocaine 5% Patch in a quantity of 30 units. This is a firm fixed price contract with a ceiling value of $5,710.63 and an ultimate completion date of July 22, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s on August 4, 2025, with a ceiling value of $1,487.80. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by August 5, 2025, with performance taking place at the contractor's corporate office location in Conshohocken. The delivery order represents a small-value pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,504.37 for Lidocaine 5% Patch (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Lidocaine 5% Patch 30s by the Defense Logistics Agency (DLA) on July 21, 2025. This firm fixed-price, competitively awarded contract has a ceiling value of $1,155.74 and an ultimate completion date of July 22, 2025. The award was not designated as a set-aside contract and represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 28, 2025, for the supply of Lidocaine 5% patches (30-count units). The contract, classified as a firm fixed-price delivery order with a ceiling value of $4,301.46, is not set-aside and was competitively awarded. The ultimate completion date is August 29, 2025, with performance occurring at the awardee's Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Lidocaine 5% patches in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,866.10 and an ultimate completion date of August 29, 2025. The contract carries no set-aside designation and was awarded competitively. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4NXDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,150.72 by the Defense Logistics Agency (DLA) on August 29, 2025, with an ultimate completion date of September 2, 2025. The contract calls for the delivery of Lidocaine 5% Patch in quantities of 30 units. This non-set-aside, competitively awarded delivery order operates under a firm fixed-price contract structure and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The underlying IDC enables the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs and other federal medical systems worldwide. AmerisourceBergen's continued participation in DLA's pharmaceutical procurement reflects its established capability to fulfill federal medical supply requirements through open competition and its role as a critical vendor for the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/29/25 |